Ranbaxy Laboratories said on Tuesday that its consolidated net profit after tax (PAT) surged over five fold to Rs 1496.8 crore for the year ended December 31, 2010.
In a filing to the BSE the company said that it had posted a profit after tax of Rs 296.5 crore in the previous fiscal.
The company’s total income rose to Rs 9380.95 crore for the year ended December 31, 2010, compared to Rs 7986.57 crore in the last year.
The company’s board, at its meeting held today, has recommended a dividend of Rs 2 per equity share for the year.